Evidence map›Paper›PMID 35960437›Full record

ArticleJournal of racial and ethnic health disparities2023

Impact of Race, Gender, and Socioeconomic Status on Symptom Severity at Time of Urologic Referral.

Joan S Ko, Christopher Corbett, Katherine M Fischer, Amanda Berry, Dana A Weiss, Christopher J Long, Stephen A Zderic, Jason P Van Batavia

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of racial and ethnic health disparities, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Reporting of race and ethnicity in studies of artificial intelligence in pediatric urology A secondary analysis of the AI-PEDURO online repository.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Joan S KoDivision of Urology, Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Christopher CorbettDepartment of Urology, University of Minnesota, Minneapolis, MN, USA.
Katherine M FischerDivision of Urology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Amanda BerryDivision of Urology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Dana A WeissDivision of Urology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Christopher J LongDivision of Urology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Stephen A ZdericDivision of Urology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jason P Van BataviaDivision of Urology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. vanbatavij@chop.edu.
University of Pennsylvania · USChildren's Hospital of Philadelphia · USChildren's Hospital of Los Angeles · USUniversity of Minnesota · US

Funding

Institutional Clinical and Translational Science AwardKL2TR001879 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$13.7M
Defining the role of CRH-expressing neurons in Barrington's Nucleus (BN) and Characterizing the other neuronal subpopulations in BNK08DK120934 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI VAN BATAVIA, JASON PHILIP · 2019 to 2022
$695k
NCATS NIH HHS KL2 TR001879NCATS NIH HHS KL2TR001879NIDDK NIH HHS K08 DK120934NIDDK NIH HHS K08DK120934
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe Dysfunctional Voiding and Incontinence Scoring System (DVISS) is a validated tool to evaluate lower urinary tract dysfunction (LUTD) severity in children. DVISS provides a quantitative score (0-35) including a quality-of-life measure, with higher values indicating more/worse symptoms. Clinically, variability exists in symptom severity when patients present to pediatric urology with LUTD. We hypothesized that symptom severity at consultation varied based on race, gender, and/or socioeconomic status.

methodsAll urology encounters at a single institution with completed modified DVISS scores 6/2015-3/2018 were reviewed. Initial visits for patients 5-21 years old with non-neurogenic LUTD were included. Patients with neurologic disorders or genitourinary tract anomalies were excluded. Wilcoxon rank sum tests compared scores between White and Black patients and between male and female patients. Multiple regression models examined relationships among race, gender, estimated median household income, and insurance payor type. All statistics were performed using Stata 15.

resultsIn total, 4086 initial patient visits for non-neurogenic LUTD were identified. Median DVISS scores were higher in Black (10) versus White (8) patients (p < 0.001). Symptom severity was higher in females (9) versus males (8) (p < 0.001). When estimated median income and insurance payer types were introduced into a multiple regression model, race, gender, and insurance payer type were significantly associated with symptom severity at presentation.

conclusionsRace, gender, and socioeconomic status significantly impact LUTS severity at the time of urologic consultation. Future studies are needed to clarify the etiologies of these disparities and to determine their clinical significance.

Indexed as

Lower Urinary Tract SymptomsQuality of LifeReferral and ConsultationSocial Determinants of HealthUrination DisordersAdolescentAdultBlack or African AmericanBlack PeopleChildChild, PreschoolFemaleHumansMaleRace FactorsSeverity of Illness IndexDysfunctional voidingGender disparitiesLower urinary tract dysfunctionPediatric urologyRacial disparitiesSocioeconomic disparities

Identifiers

PMID35960437
PMCPMC10339358
OpenAlexW4290840873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.